Sunnyvale, CA (PRWEB) November 21, 2013
SIGNL, a service that tracks the fastest-growing companies worldwide, ranked Clinovo at 9th position among 494 companies in the pharmaceutical, medical device and biotechnology industry. From startups to big businesses, SIGNL measures the success of a company’s engine by aggregating and quantifying evidence of a business growth.
At the 9th position, Clinovo performed significantly well among 494 biotechnology companies, which included some of the leading pharmaceutical, medical device and biotechnology companies in the industry such as Illumina, Ariad Pharmaceuticals, OncoMed, Acorda, Intermune and more.
SIGNL’s sophisticated ranking algorithms measured and compared thousands of companies' key performance indicators and presence on the internet over the last few months. The ranking is based on measurable metrics, including web traffic increase, web mentions, and detailed metrics on social media networks such as Facebook and Twitter. Clinovo's website has increased by 194% over the last three months and Clinovo's Twitter followers grew to 728, a 96% increase in the same period of time.
With this ranking, Clinovo demonstrates its active online presence with strong participation in industry-related discussions. The company regularly releases new white papers, blog posts, and webinars. Also very active offline, the California-based CRO sponsors several national clinical trial events every year including SCDM (Society for Clinical Data Management), PharmaSUG, Outsourcing in Clinical Trials as well as DIA (Drug Information Association). Clinovo also organizes the
Copyright©2012 Vocus, Inc.
All rights reserved